IL89750A0 - Pharmaceutical compositions for the treatment of melanoma comprising a combination of il-2 and dtic - Google Patents

Pharmaceutical compositions for the treatment of melanoma comprising a combination of il-2 and dtic

Info

Publication number
IL89750A0
IL89750A0 IL89750A IL8975089A IL89750A0 IL 89750 A0 IL89750 A0 IL 89750A0 IL 89750 A IL89750 A IL 89750A IL 8975089 A IL8975089 A IL 8975089A IL 89750 A0 IL89750 A0 IL 89750A0
Authority
IL
Israel
Prior art keywords
dtic
melanoma
treatment
combination
pharmaceutical compositions
Prior art date
Application number
IL89750A
Other languages
English (en)
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of IL89750A0 publication Critical patent/IL89750A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL89750A 1988-03-28 1989-03-27 Pharmaceutical compositions for the treatment of melanoma comprising a combination of il-2 and dtic IL89750A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/174,000 US4999339A (en) 1988-03-28 1988-03-28 Combination therapy of IL-2 and DTIC for the treatment of melanoma

Publications (1)

Publication Number Publication Date
IL89750A0 true IL89750A0 (en) 1989-09-28

Family

ID=22634400

Family Applications (1)

Application Number Title Priority Date Filing Date
IL89750A IL89750A0 (en) 1988-03-28 1989-03-27 Pharmaceutical compositions for the treatment of melanoma comprising a combination of il-2 and dtic

Country Status (8)

Country Link
US (1) US4999339A (fr)
EP (1) EP0422010A1 (fr)
JP (1) JPH03503647A (fr)
KR (1) KR900700124A (fr)
AU (1) AU3427389A (fr)
IL (1) IL89750A0 (fr)
WO (1) WO1989009062A1 (fr)
ZA (1) ZA892275B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5229109A (en) * 1992-04-14 1993-07-20 Board Of Regents, The University Of Texas System Low toxicity interleukin-2 analogues for use in immunotherapy
AU2001266557A1 (en) * 2000-04-12 2001-10-23 Human Genome Sciences, Inc. Albumin fusion proteins
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
CA2446739A1 (fr) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Proteines hybrides beta-1 de chimiokine
EP2261250B1 (fr) 2001-12-21 2015-07-01 Human Genome Sciences, Inc. Protéines de fusion d'albumine et GCSF
WO2003059934A2 (fr) * 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Proteines de fusion d'albumine
CA2513213C (fr) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Proteines hybrides d'albumine
AU2005218759B2 (en) * 2004-02-27 2009-07-16 Antisense Pharma Gmbh Pharmaceutical composition
US20080227762A1 (en) * 2004-03-02 2008-09-18 Wisconsin Alumni Research Foundation Lupeol anti-tumor agent and uses thereof
WO2013177187A2 (fr) * 2012-05-22 2013-11-28 Massachusetts Institute Of Technology Traitement de tumeur synergique avec du pk il-2 étendu et des agents thérapeutiques
US9758786B2 (en) 2016-02-09 2017-09-12 Autotelic, Llc Compositions and methods for treating pancreatic cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
BE1001901A3 (fr) * 1986-04-24 1990-04-10 Cetus Corp Composition a utiliser en therapie combinee au moyen d'interleukine-2 et de glucocorticoides.

Also Published As

Publication number Publication date
KR900700124A (ko) 1990-08-11
AU3427389A (en) 1989-10-16
ZA892275B (en) 1990-11-28
WO1989009062A1 (fr) 1989-10-05
EP0422010A1 (fr) 1991-04-17
JPH03503647A (ja) 1991-08-15
US4999339A (en) 1991-03-12

Similar Documents

Publication Publication Date Title
IL90067A0 (en) 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them
NZ222980A (en) 3-aryloxy-3-substituted propanamines and pharmaceutical compositions
NZ223096A (en) Peptidylaminodiols and pharmaceutical compositions
IL88988A0 (en) Didehydro-vitamin d3 derivatives and pharmaceutical compositions containing them
NZ228754A (en) Vitamin d analogues and pharmaceutical compositions
NZ220880A (en) Di-tert-butyl-phenol derivatives and pharmaceutical compositions
HUT50278A (en) New cosmetic and medicinal cosmetic compositions
NZ220171A (en) Dihydro-benzopyran derivatives and pharmaceutical compositions
NZ226002A (en) Peptidylheterocyclic compounds and pharmaceutical compositions
NZ221933A (en) Catechol derivatives and pharmaceutical compositions
NZ228247A (en) Substituted thiazolidine-2,4-diones and pharmaceutical compositions
NZ230631A (en) Nitrate esters and pharmaceutical compositions
IL89750A0 (en) Pharmaceutical compositions for the treatment of melanoma comprising a combination of il-2 and dtic
IL78939A0 (en) N-substituted arylalkyl-and arylalkylene-aminoheterocyclics and pharmaceutical compositions containing them
NZ210105A (en) Oxazolidine derivatives and pharmaceutical compositions
NZ217798A (en) N-substituted diphenylpiperidines and pharmaceutical compositions
NZ233011A (en) Thieno-triazole-diazepine and pharmaceutical compositions
NZ226450A (en) Crystalline-1-carbacephalosporin and pharmaceutical compositions
NZ218237A (en) Oxazolone derivatives and pharmaceutical compositions
IL96747A0 (en) Oxazole derivatives and pharmaceutical compositions containing them
NZ217871A (en) Oxazole derivatives and pharmaceutical compositions
GB8808758D0 (en) Nutritional and medicinal compositions
IL90065A0 (en) 1alpha-hydroxyvitamin-d homologs and pharmaceutical compositions containing them
GB2222768B (en) Analgesic compounds and compositions
NZ223051A (en) Carbamoyloxylabdane derivatives and pharmaceutical compositions